Regenxbio Inc (RGNX) — Capital Reinvestment Ratio
Latest as of March 2025:
0.03x
Regenxbio Inc (RGNX) has a Capital Reinvestment Ratio of 0.03x as of March 2025, meaning it reinvests 0% of its operating cash flow ($33.63 Million) in capital expenditures ($1.02 Million). See Regenxbio Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$33.63 Million
USD
Capital Expenditures
$1.02 Million
USD
Data as of
Mar 2025
Most recent filing
Regenxbio Inc Capital Reinvestment Ratio (2018–2021)
This chart tracks Regenxbio Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Regenxbio Inc (2018–2021)
Year-by-year Capital Reinvestment Ratio for Regenxbio Inc from 2018 to 2021. For live market cap and broader valuation context, see Regenxbio Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.38x | $218.88 Million | $84.17 Million | ▲ +203.1% |
| 2018 | 0.13x | $104.65 Million | $13.28 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow